
Pfizer Ltd. (PFIZER) Share Price near 52-week low after 0.33% drop
Updated: 17 Sept 2026 • 9:46 am
Posted by:

Pfizer Ltd. Share Price is Rs 4,000, down 0.33% today, and remains close to its 52-week low with a market capitalisation of Rs 18,488.26 crore. The move keeps PFIZER in focus for Pfizer Ltd. Share Price Today searches, especially as the stock trades well below its 50-day and 200-day moving averages. The supplied data confirms the price event, but it does not establish a company-specific catalyst. That is why Pfizer Ltd. Stock News is being read mainly through price action, valuation and sector context. In Univest terms, this is a classic near-low setup where investors usually examine whether the decline reflects broader market sentiment, stretched technical positioning or a normal reset in price after an earlier run. Univest also highlights that the event is relevant because the stock is now trading near a yearly low rather than at a fresh high point in its range.
Pfizer Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,000 |
| Previous Close | Rs 4,013.25 |
| Today's Move | Rs -13.25 (-0.33%) |
| Open | Rs 3,991.05 |
| High | Rs 4,016.8 |
| Low | Rs 3,990 |
| Turnover | Rs 0.14 crore |
| Market Capitalisation | Rs 18,488.26 crore |
Pfizer Ltd. (PFIZER) traded at Rs 4,000 versus the previous close of Rs 4,013.25, a fall of 0.33%. The stock opened at Rs 3,991.05, reached a high of Rs 4,016.8, touched a low of Rs 3,990.
Pfizer Ltd. Share Price Today shows a narrow intraday move, but the stock still sits close to its 52-week low. PFIZER opened at Rs 3,991.05, moved between Rs 3,990 and Rs 4,016.80, and last traded at Rs 4,000 against the previous close of Rs 4,013.25. The day change of Rs -13.25 and -0.33% reflects mild selling pressure rather than a sharp breakdown. Turnover stood at Rs 0.14 crore, while market capitalisation remained Rs 18,488.26 crore, keeping Pfizer Ltd. Share Price in the large-cap healthcare discussion set. The current price is also Rs 648.20 below the 50 DMA and Rs 713.80 below the 200 DMA, which shows that the broader share price trend is still weaker than the short-term daily range suggests. In UniVest-style stock analysis, the key takeaway is simple: the price action confirms weakness, but not a panic move, and the stock remains positioned near support-zone territory around the 52-week low. That sets up the technical read that investors normally check next.
Pfizer Ltd. (PFIZER) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,488.26 crore |
| P/E Ratio | 24.97x |
| P/B Ratio | 4.17x |
| ROE | 17.16% |
| ROCE | 23.39% |
| EPS | Rs 160.7 |
| Book Value Per Share | Rs 963.41 |
| Dividend Yield | 1.87% |
Pfizer Ltd. (PFIZER) fundamental metrics show P/E 24.97x, P/B 4.17x, ROE 17.16%, ROCE 23.39%. These figures provide context only and are not a buy or sell signal.
Pfizer Ltd. has a market capitalisation of Rs 18488.26 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.97x, P/B at 4.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.87%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 28.19x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 24.97x |
| Benchmark Median P/E | 28.19x |
| Benchmark Average P/E | 40.48x |
| Benchmark P/E Range | 0x to 661.74x |
| Company P/B Ratio | 4.17x |
| Benchmark Median P/B | 2.92x |
| Company ROE | 17.16% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 23.39% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 18,488.26 crore |
| Benchmark Median Market Cap | Rs 730.86 crore |
Pfizer Ltd. (PFIZER) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Pfizer Ltd. (PFIZER) has a P/E ratio of 24.97x, which is below the benchmark median of 28.19x, a difference of -11.42%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.7%, a difference of +46.67%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.61%, a difference of +71.86%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| ONESOURCE SPECL PHARMA L | ONESOURCE | 18,332.18 | 0 | 3.13 | -1.26 | 0.44 |
| Eris Lifesciences Ltd. | ERIS | 18,168.27 | 28.1 | 4.49 | 19.23 | 14.47 |
| Shilpa Medicare Ltd. | SHILPAMED | 17,834.13 | 61.02 | 6.75 | 9.82 | 11.43 |
| Caplin Point Laboratories Ltd. | CAPLIPOINT | 19,541.09 | 29.52 | 5.35 | 20.79 | 24.97 |
| Glenmark Life Sciences Ltd. | ALIVUS | 16,837.49 | 27.92 | 4.83 | 18.41 | 24.61 |
Pfizer Ltd. (PFIZER) has a P/E ratio of 24.97x compared with the displayed peer median of 28.1x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 17.16% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 18,488.26 crore. Among the 5 peers shown, 1 have a larger market capitalisation.
Why Investors Are Watching Pfizer Ltd.
- Pfizer Ltd. Share Price is trading near its 52-week low, so the current price action is drawing attention from Stock Market Today screens.
- The stock remains below its 50 DMA and 200 DMA, which keeps the technical tone weak rather than strongly trending.
- Valuation is below the industry median on P/E, while ROE and ROCE remain above benchmark medians.
- Market capitalisation is Rs 18,488.26 crore, making PFIZER a notable healthcare name in Stocks in News discussions.
- Recent revenue and profit figures support continued interest in Pfizer Ltd. Fundamental Analysis and Pfizer Ltd. Stock News.
About Pfizer Ltd.
Pfizer Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s business profile, as reflected in the supplied data, is that of a large listed pharma player with meaningful profitability and a strong return profile. Its market capitalisation of Rs 18,488.26 crore places it among the bigger names in the peer set, while recent company financials show revenue of Rs 6,531.7 crore and net profit of Rs 2,044.7 crore in Jun 26. Those figures help explain why Pfizer Ltd. Share Price remains relevant even when the stock trades near a yearly low. The earnings metrics also provide context: EPS of Rs 160.7, book value per share of Rs 963.41 and dividend yield of 1.87% point to a mature listed company with established financials. On Univest, this combination is useful for readers comparing Pfizer Ltd. Stock Performance with other healthcare stocks and checking whether the current share price is being driven by business fundamentals or by price action alone.
Track Pfizer Ltd. Share Price on Univest
Use Pfizer Ltd. (PFIZER) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors tracking Pfizer Ltd. Share Price can use Univest to review live share price updates, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and broader market insights in one place. That makes it easier to follow Pfizer Ltd. Share Price Today, compare PFIZER with peers and place the move inside the healthcare sector context. Univest also helps readers monitor Pfizer Ltd. Company News, Pfizer Ltd. Latest News and Pfizer Ltd. Stock Analysis without relying on fragmented market updates. For users searching Pfizer Ltd. Share Price Live or Pfizer Ltd. Share Price Update, the platform keeps the focus on verified market data rather than speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Pfizer Ltd. Share Price near a 52-week low?
Ans. Pfizer Ltd. Share Price is near a 52-week low because the stock is trading at Rs 4,000, below its 50 DMA and 200 DMA. The supplied data confirms price weakness, but not a company-specific catalyst.
What is Pfizer Ltd. Share Price Today?
Ans. Pfizer Ltd. Share Price Today is Rs 4,000, after a decline of Rs -13.25 or -0.33% from the previous close of Rs 4,013.25. The session range stayed narrow between Rs 3,990 and Rs 4,016.80.
How close is PFIZER to its 52-week low?
Ans. PFIZER is trading close to its 52-week low, which is why it appears in stocks at 52-week low screens. The move is relevant because the current price is still well below its longer-term moving averages.
What do Pfizer Ltd. financial results show?
Ans. Pfizer Ltd. financial results show revenue of Rs 6,531.7 crore and net profit of Rs 2,044.7 crore in Jun 26. Those figures support a profitable business even while the share price trades near a yearly low.
Is Pfizer Ltd. Share Price expensive on valuation?
Ans. Pfizer Ltd. Share Price trades at a P/E of 24.97, below the industry median of 28.19. Its P/B of 4.17 is above the median of 2.92, so the valuation picture is mixed.
How do Pfizer Ltd. ROE and ROCE compare with peers?
Ans. Pfizer Ltd. shows ROE of 17.16 and ROCE of 23.39. That is stronger than the industry medians and compares well with several peers, though Caplin Point and Glenmark Life Sciences are slightly higher on ROCE.
What does Pfizer Ltd. market cap indicate?
Ans. Pfizer Ltd. market cap of Rs 18,488.26 crore places it above the industry median and above the sector average. Market capitalisation reflects company size, not quality, but it does support index and peer attention.
Should investors track Pfizer Ltd. Stock News?
Ans. Investors can track Pfizer Ltd. Stock News because the stock is near a 52-week low, the valuation is near sector norms, and profitability remains solid. That combination keeps Pfizer Ltd. Share Price relevant for market updates.
Where can I monitor Pfizer Ltd. Share Price Live?
Ans. Pfizer Ltd. Share Price Live can be monitored on Univest, where users can review price action, technical indicators, fundamental ratios, peer comparison and 52-week levels. The platform keeps PFIZER analysis in one place.
Recent Articles

Max Financial Services Ltd. (MFSL): Max Financial Services Share Price rises 2.86% as MFSL gains today
17 September 2026

Alok Industries Share Price Hits Fresh 52-Week Low at Rs 7.06: Key Reasons Behind the Fall
17 September 2026

AIA Engineering Ltd. (AIAENG): AIA Engineering Share Price rises 3.07% to Rs 3,907
17 September 2026

Easy Trip Planners Stock Sinks to New 52-Week Low at Rs 5.71: Key Reasons Behind the Decline
17 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Max Financial Services Ltd. (MFSL): Max Financial Services Share Price rises 2.86% as MFSL gains today
Alok Industries Share Price Hits Fresh 52-Week Low at Rs 7.06: Key Reasons Behind the Fall
AIA Engineering Ltd. (AIAENG): AIA Engineering Share Price rises 3.07% to Rs 3,907
Easy Trip Planners Stock Sinks to New 52-Week Low at Rs 5.71: Key Reasons Behind the Decline
HDFC Life Insurance Company Ltd. (HDFCLIFE): HDFC Life Insurance Share Price Rises 3.49% to Rs 549.10

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





